| Literature DB >> 35010420 |
Hsiang-Yun Chou1, Yu-Chun Lo2, Ya-Wen Tsai1, Chia-Li Shih1, Chieh-Ting Yeh3.
Abstract
This study aimed to explore the quality and stability of post-acute care for patients with stroke, including their functional outcomes, mental health and medical care in Taiwan during the COVID-19 pandemic. In this retrospective case-control study-based on propensity score matching-we assessed 11 patients admitted during the pandemic period (in 2021) and 11 patients admitted during the non-pandemic period (in 2020). Functional outcomes, including the scores of the modified Rankin Scale, Barthel Index, EuroQoL-5 Dimension, Lawton-Brody instrumental activities of daily living, Berg Balance Scale, 5-metre walking speed and 6-min walking distance, were determined. Data on the length of acute care, length of post-acute care, destination after discharge and 14-days readmission were used to evaluate the quality of medical care. The Wilcoxon signed-rank test was used to compare functional performance before and after rehabilitation. The pandemic group showed no significant improvement in the scores of EuroQoL-5 Dimension, a self-reported health status assessment (p = 0.13), with the anxiety or depression dimension showing a negative effect (r = 0.21). Post-acute care programmes can efficiently improve the functional performance of patients with stroke during the COVID-19 pandemic in Taiwan. Mental health should therefore be simultaneously maintained while rehabilitating physical function.Entities:
Keywords: COVID-19; anxiety; depression; functional outcome; mental health; post-acute care; rehabilitation; stroke
Mesh:
Year: 2021 PMID: 35010420 PMCID: PMC8751212 DOI: 10.3390/ijerph19010162
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Patients’ characteristics before and after propensity score matching (PSM).
| Before Propensity Score Matching | After Propensity Score Matching | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables | Pandemic Group | Non-Pandemic Group | SMD |
| Pandemic Group | Non-Pandemic Group | SMD |
| |||||
| Demographics | Mean (SD) or | Mean (SD) or | |||||||||||
| Age, years | 53.64 (15.85) | 63.44 (14.65) | 0.642 | 0.04 * | 53.64 (15.85) | 52.91 (17.71) | 0.043 | 0.92 | |||||
| Sex | Female | 2 (18.2%) | 26 (31.7) | 0.320 | 0.33 | 2 (18.2%) | 2 (18.2%) | 0 | 1.0 | ||||
| Male | 9 (81.8%) | 56 (68.3%) | 9 (81.8%) | 9 (81.8%) | |||||||||
| Clinical Attributes | |||||||||||||
| Stroke Type | 0.120 | 0.71 | 0 | 1.0 | |||||||||
| Ischemic | 9 (81.8%) | 63 (76.8%) | 9 (81.8%) | 9 (81.8%) | |||||||||
| Hemorrhagic | 2 (18.2%) | 19 (23.2%) | 2 (18.2%) | 2 (18.2%) | |||||||||
| Hypertension | 10 (90.9%) | 78 (95.1%) | 0.152 | 0.57 | 10 (90.9%) | 10 (90.9%) | 0 | 1.0 | |||||
| Coronary Artery Disease | 3 (27.3%) | 20 (24.4%) | 0.067 | 0.84 | 3 (27.3%) | 3 (27.3%) | 0 | 1.0 | |||||
| Diabetes Mellitus | 2 (18.2%) | 29 (35.4%) | 0.382 | 0.22 | 2 (18.2%) | 1 (9.1%) | 0.252 | 0.56 | |||||
| Hyperlipidemia | 6 (54.5%) | 35 (42.7%) | 0.235 | 0.46 | 6 (54.5%) | 6 (54.5%) | 0 | 1.0 | |||||
| Previous Stroke | 3 (27.3%) | 17 (21.5%) | 0.137 | 0.63 | 3 (27.3%) | 2 (18.2%) | 0.206 | 0.63 | |||||
| Common Risk Factors | |||||||||||||
| Smoking | 6 (54.5%) | 16 (19.5%) | 0.753 | 0.05 | 6 (54.5%) | 6 (54.5%) | 0 | 1.0 | |||||
| Drinking | 3 (27.3%) | 12 (14.6%) | 0.289 | 0.29 | 3 (27.3%) | 3 (27.3%) | 0 | 1.0 | |||||
| Pre-rehabilitation Functional Status | |||||||||||||
| Mean | Median | Mean (SD) | Median | SMD |
| Mean (SD) | Median | Mean (SD) | Median | SMD |
| ||
| mRS | 3.55 | 4 | 3.65 (0.48) | 4 | 0.20 | 0.52 | 3.55 (0.52) | 4 | 3.64 | 4 | 0.175 | 0.67 | |
| BI | 50.91 | 50 | 48 | 50 | 0.132 | 0.66 | 50.91 (15.12) | 50 | 50 | 55 | 0.054 | 0.95 | |
| EQ-5D | 8.82 | 8 | 8.95 (1.45) | 8 | 0.096 | 0.77 | 8.82 (1.25) | 8 | 8.64 | 8 | 0.157 | 0.85 | |
| IADL | 1.09 | 1 | 1.24 (1.19) | 1 | 0.134 | 0.69 | 1.09 (1.04) | 1 | 1.36 | 2 | 0.261 | 0.51 | |
| BBS | 22.73 (16.13) | 20 | 18.04 (14.49) | 11.5 | 0.306 | 0.32 | 22.73 (16.13) | 20 | 22.45 (13.71) | 23 | 0.019 | 0.95 | |
SD: standard deviation; mRS: modified Rankin Scale; BI: Barthel Index; EQ-5D: EuroQoL-5 Dimension; IADL: Lawton–Brody instrumental activities of daily living; BBS: Berg Balance Scale; SMD: standardized mean difference. Values are expressed as mean (SD), median and interquartile range (IQR), or n %. * Statistically significant (p < 0.05).
Total score for each functional status measure before and after the PAC program in both groups.
| Measures | Pandemic Group ( | Non-Pandemic Group ( | ||||
|---|---|---|---|---|---|---|
| Before PAC | After PAC |
| Before PAC | After PAC |
| |
| mRS | 4 (3–4) | 3 (2–4) | 0.02 * | 4 (3–4) | 2 (2–3) | 0.01 * |
| BI | 50 (40–65) | 80 (60–100) | <0.01 * | 55 (40–60) | 85 (70–95) | <0.01 * |
| EQ-5D | 8 (8–10) | 8 (6–9) | 0.13 | 8 (8–9) | 7 (5–8) | <0.01 * |
| IADL | 1 (0–2) | 4 (0–5) | 0.02 * | 2 (0–2) | 3 (2–4) | <0.01 * |
| BBS | 20 (5–36) | 52 (30–56) | <0.01 * | 23 (9–38) | 44 (27–50) | <0.01 * |
| 5MWS | 0 (0–0.21) | 0.56 (0.13–1.22) | <0.01 * | 0 (0–0) | 0.42 (0–0.48) | 0.01 * |
| 6MWD | 0 (0–100) | 130 (40–416) | <0.01 * | 0 (0–0) | 150 (0–230) | 0.01 * |
PAC: post-acute care; mRS: modified Rankin Scale; BI: Barthel Index; EQ-5D: EuroQoL-5 Dimension; IADL: Lawton–Brody instrumental activities of daily living; BBS: Berg Balance Scale; 5MWS: 5-m walking speed; 6MWD: 6-min walking distance. Values are expressed as median and interquartile range (IQR), i.e., 4 (3–4) means the median is 4 and the interquartile range is from 3 to 4. * Statistically significant (p < 0.05).
Differences in effect size (ES) in each functional status measure before and after the PAC program: comparison between different groups.
| Measures | Pandemic Group ( | Non-Pandemic Group ( | |||||
|---|---|---|---|---|---|---|---|
| Before PAC | After PAC | ES1 | Before PAC | After PAC | ES2 | ES1-ES | |
| mRS | 4 (3–4) | 3 (2–4) | −0.50 | 4 (3–4) | 2 (2–3) | −0.53 | 0.03 |
| BI | 50 (40–65) | 80 (60–100) | 0.57 | 55 (40–60) | 85 (70–95) | 0.63 | −0.06 |
| EQ-5D | 8 (8–10) | 8 (6–9) | −0.32 | 8 (8–9) | 7 (5–8) | −0.55 | 0.23 |
| IADL | 1 (0–2) | 4 (0–5) | 0.52 | 2 (0–2) | 3 (2–4) | 0.61 | −0.09 |
| BBS | 20 (5–36) | 52 (30–56) | 0.63 | 23 (9–38) | 44 (27–50) | 0.63 | 0 |
| 5MWS | 0 (0–0.21) | 0.56 (0.13–1.22) | 0.57 | 0 (0–0) | 0.42 (0–0.48) | 0.54 | 0.03 |
| 6MWD | 0 (0–100) | 130 (40–416) | 0.57 | 0 (0–0) | 150 (0–230) | 0.54 | 0.03 |
PAC: post-acute care; mRS: modified Rankin Scale; BI: Barthel Index; EQ-5D: EuroQoL-5 Dimension; IADL: Lawton–Brody instrumental activities of daily living; BBS: Berg Balance Scale; 5MWS: 5-m walking speed; 6MWD: 6-min walking distance; ES, effect size. Values are expressed as median and interquartile range (IQR), i.e., 4 (3–4) means the median is 4 and the interquartile range is from 3 to 4. ES1 and ES2 indicate the change in functional outcome in pandemic and non-pandemic groups, respectively. ES1-ES2 indicates the difference between both two groups.
The five dimensions in EQ-5D before and after PAC program: comparison between different groups.
| Dimensions | Pandemic Group ( | Non-Pandemic Group ( | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Before PAC | After PAC |
| ES1 | Before PAC | After PAC |
| ES2 | ES1-ES | |
| Mobility | 2 (2–2) | 2 (1–2) | 0.32 | −0.21 | 2 (2–2) | 1 (1–2) | <0.01 * | −0.53 | 0.35 |
| Self-Care | 2 (2–2) | 2 (1–2) | 0.06 | −0.40 | 2 (2–2) | 2 (1–2) | 0.04 * | −0.43 | 0.03 |
| Usual Activities | 2 (2–3) | 2 (2–3) | 0.08 | −0.37 | 2 (2–3) | 2 (1–2) | <0.01 * | −0.56 | 0.19 |
| Pain or Discomfort | 1 (1–1) | 1 (1–1) | 0.32 | −0.21 | 1 (1–1) | 1 (1–1) | 0.32 | −0.21 | 0 |
| Anxiety or Depression | 1 (1–1) | 1 (1–1) | 0.32 | 0.21 | 1 (1–1) | 1 (1–1) | 0.16 | −0.30 | 0.51 |
PAC: post-acute care; EQ-5D: EuroQoL-5 Dimension; ES, effect size. ES1 means the change in functional outcome in the pandemic group; ES2 means the change in functional outcome in the non-pandemic group. ES1-ES2 indicates the difference between the two groups. Values are expressed as median and interquartile range (IQR), i.e., 4 (3–4) means the median is 4 and the interquartile range is from 3 to 4. * Statistically significant (p < 0.05).
Quality of medical care in both groups.
| Pandemic Group | Non-Pandemic Group |
| ||
|---|---|---|---|---|
| Acute Care LOS, day | 16.09 (6.49) | 15.36 (4.34) | 0.76 | |
| PAC LOS, day | 32.73 (10.97) | 36.64 (12.40) | 0.44 | |
| Destination after Discharge | 1 | |||
| Household | 10 (91%) | 10 (91%) | ||
| Nursing Home | 1 (9%) | 1 (9%) | ||
| Readmission in 14 days | Yes | 0 (0%) | 0 (0%) | 1 |
| 6MWD ≥ 205 | 4 (36%) | 3 (27%) | 0.66 | |
LOS: length of stay; PAC: post-acute care; 6MWD: 6-min walking distance. Values are expressed as mean (SD) or n %.